News @Gotham

July 17, 2019 - Gotham Therapeutics and Mercachem Announce Progress in Compound Library Development Tailored for Epitranscriptomic Drug Discovery

In July 2019, Gotham Therapeutics and Mercachem announced the generation of a high-quality compound library tailor-made for accelerated hit generation and hit-to-lead expansion against large parts of the epitranscriptomic target space. The research led to a collection of over 2,000 analogues and over 80 distinct chemotypes displaying an up to 1,000-fold increased affinity to epitranscriptomic targets.

 
nyc-muc-2-blurred.jpg
3.jpg

PRESS RELEASE

Gotham and ZoBio Achieve Significant Milestone in Epitranscriptomic Drug Discovery Collaboration

In May 2019, Gotham Therapeutics and ZoBio announced significant progress made as part of their collaboration to identify therapeutic lead candidates for Gotham’s initial portfolio of epitranscriptomic targets.

PRESS RELEASE

Gotham Strengthens Board of Directors and Scientific Advisory Board

In February 2019, Gotham Therapeutics announced the appointment of Carlo Incerti, M.D., Ph.D. as an independent Board Member. In addition, the company added Thomas Tuschl, Ph.D. as a Scientific Advisor.

PRESS RELEASE

Gotham Therapeutics Launches with $54 Million Series A

In October 2018, Gotham Therapeutics debuted with a $54 million Series A financing co-led by founding investor Versant Ventures, Forbion and S.R. One.

Gotham-Group.jpg

UPCOMING EVENT

BIO-Europe

Meet the team at BIO-Europe at the Hamburg Messe, Hamburg, Germany, November 11–13, 2019.

UPCOMING EVENT

Targeting RNA Congress

Meet the team at The Targeting RNA Congress in Frankfurt, Germany, November 26-27, 2019.

UPCOMING EVENT

2nd RNA-Targeted Drug Discovery Summit

Meet the team at the 2nd RNA-Targeted Drug Discovery Summit at The Westin Copley Place, Boston, MA, December 2-4, 2019.

UPCOMING EVENT

SCT Fall One-Day Symposium - Drug Discovery in the RNA World

Meet the team at the SCT Fall One-Day Symposium - Drug Discovery in the RNA World at the Maison des Associations de Solidarité, Paris, France, December 11, 2019.

Stay In Touch! 

Gotham Therapeutics will be at the forefront of epitranscriptomics research and drug discovery. Staying in touch with us means staying up-to-date on the field.

contact.jpg